Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.

Erdogan, M; Karadeniz, M; Berdeli, A; Tamsel, S; Ertan, Y; Uluer, H; Yilmaz, C; Tuzun, M; Kabalak, T; Ozgen, A G

Erdogan, M; Karadeniz, M; Berdeli, A; Tamsel, S; Ertan, Y; Uluer, H; Yilmaz, C; Tuzun, M; Kabalak, T; Ozgen, A G.

Affiliation

Erdogan M; Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey. drmerdogan61@yahoo.com

J Endocrinol Invest ; 30(5): 411-6, 2007 May.

Article in En | MEDLINE | ID: mdl-17598974

Subject(s)

Carcinoma, Papillary/genetics; Fas Ligand Protein/genetics; Thyroid Neoplasms/genetics; fas Receptor/genetics; Adult; Apoptosis/genetics; Carcinoma, Papillary/epidemiology; Carcinoma, Papillary/pathology; Female; Gene Frequency; Genetic Predisposition to Disease/epidemiology; Genotype; Humans; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Thyroid Neoplasms/epidemiology; Thyroid Neoplasms/pathology; Turkey/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Carcinoma, Papillary / Fas Receptor / Fas Ligand Protein Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Endocrinol Invest Year: 2007 Document type: Article Affiliation country: Turkey Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links